Mindful Innovation
Mastering Challenges. Compassion for Patients. Transforming Medicine.
At Marinus Pharmaceuticals, our passionate team of experts is constantly innovating with the aim to drastically improve lives affected by rare epilepsies and CNS disorders.
Expanded Access Program
Marinus launched the Expanded Access Program (EAP) for CDKL5 in January 2020.
This program allows qualified patients to receive the investigational drug ganaxolone for CDD.
We are laser focused on treating patients with severe, rare forms of epilepsy, implementing a clinical trial strategy that is guided by our strong scientific rationale, and unlocking the potential of ganaxolone across a range of CNS disorders.
— Scott Braunstein, M.D., CEO, Marinus Pharmaceuticals
-
Ganaxolone
Dedicated to the development of ganaxolone
We are dedicated to maximizing the value of ganaxolone as a first-in-class innovative CNS therapy with a portfolio of diversified indications.
-
Pipeline
Discover the science behind ganaxolone
Ganaxolone, through its validated GABAA mechanism, has opportunities in orphan indications and in chronic and acute care settings.
-
Focus Areas
Focused on rare seizure and CNS disorders
We are developing breakthrough therapies in status epilepticus, tuberous sclerosis complex, and CDKL5 deficiency disorder.
-
Trials
Our goal is developing safe and effective treatments
We are conducting high quality research in-house, with our scientific advisory board and external consultants to ensure patients are receiving innovative and safe treatment options.
Providing a range of clinical trials to develop innovative treatments for patients
Status Epilepticus
Striving to maintain seizure control
Developing therapies with the potential to provide rapid cessation of status epilepticus and prevent escalation of treatment
Rare Orphan Epilepsies
Aspiring to give children significantly less seizures and better quality of life
Ganaxolone offers the potential to safely decrease seizure frequency in children with refractory epilepsy
Advocacy & Related Activities
Fostering a community for those impacted by rare diseases
Collaborating with key groups to support patients and their families, working to lessen the burden of rare diseases and disorders
Want to make an impact?
We are always looking for dedicated and passionate professionals who want to make a positive difference in the lives of those affected by rare epilepsies and CNS disorders.